The role of CRF and CRF-related peptides in the dark side of addiction
- 16 February 2010
- journal article
- review article
- Published by Elsevier BV in Brain Research
- Vol. 1314, 3-14
- https://doi.org/10.1016/j.brainres.2009.11.008
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (DK26741)
- National Institute on Diabetes and Digestive and Kidney Diseases (DA04043, DA04398,)
- National Institute on Drug Abuse (DA023597)
- the National Institute on Alcohol Abuse and Alcoholism, and the Pearson Center for Alcoholism and Addiction Research (AA08459)
This publication has 129 references indexed in Scilit:
- Brain stress systems in the amygdala and addictionBrain Research, 2009
- Corticotropin-Releasing Factor-1 Receptor Activation Mediates Nicotine Withdrawal-Induced Deficit in Brain Reward Function and Stress-Induced RelapseBiological Psychiatry, 2009
- Differential sensitivity of the perioculomotor urocortin-containing neurons to ethanol, psychostimulants and stress in mice and ratsNeuroscience, 2009
- A Role for Brain Stress Systems in AddictionNeuron, 2008
- MPZP: A novel small molecule corticotropin-releasing factor type 1 receptor (CRF1) antagonistPharmacology Biochemistry and Behavior, 2008
- Urocortin 1 microinjection into the mouse lateral septum regulates the acquisition and expression of alcohol consumptionNeuroscience, 2008
- CRF1 receptor antagonists attenuate escalated cocaine self-administration in ratsPsychopharmacology, 2007
- A CRF2 agonist administered into the central nucleus of the amygdala decreases ethanol self-administration in ethanol-dependent ratsBrain Research, 2007
- Dependence-induced increases in ethanol self-administration in mice are blocked by the CRF1 receptor antagonist antalarmin and by CRF1 receptor knockoutPharmacology Biochemistry and Behavior, 2007
- Corticotropin-Releasing Factor 1 Antagonists Selectively Reduce Ethanol Self-Administration in Ethanol-Dependent RatsBiological Psychiatry, 2007